President Trump is promising a new healthcare plan for the nation in recent media interviews, though there have been scant details so far.

The pharmaceutical industry is taking action after the Trump administration finalized a rule that would require drugmakers to publish list prices in television ads.

The Trump administration was warned that its policy changes undermining the Affordable Care Act would cause disruption to healthcare coverage and likely increase taxes, according to a leaked internal memo, first reported by Politico. CMS Administrator Seema Verma penned the memo in August 2018 and outlined how several policy changes could negatively impact the ACA market.

As Medicare for all continues to gain traction among American voters and more Democratic presidential nominees take up the platform, the American Medical Association has decided not to support such an initiative.

HHS, with the Departments of Labor and Treasury, has issued a new rule to expand the use of health reimbursement coverage, which provide tax-preferred funds for employees to buy their own insurance on the individual market.

The sky-high costs of receiving medical care and the reality of asking for help to pay those bills are being highlighted by The Huffington Post in a series titled “Life and Death: Stories from Inside America’s GoFundMe Health Care System.”

CMS wants to reduce the paperwork burden for the healthcare industry and is asking for stakeholder input on its initiative, Patients over Paperwork, the agency announced June 6.

Drugmaker Pfizer hid that one of its powerful anti-inflammatory drugs for rheumatoid arthritis therapy, Enbrel, reduced the risk of Alzheimer’s disease by 64%, according to a report by the Washington Post.